다우존스 지수

같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Prelude Therapeutics Inc (PRLD)
Prelude Therapeutics Inc (PRLD) 뉴스

PRLD

Prelude Therapeutics (PRLD)

Prelude Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:PRLD

1 2 3 4 5 6 7 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/09	20:01	GlobeNewswire Inc.	Prelude Therapeutics to Participate in Citizens JMP Life Sciences Conference	NASDAQ:PRLD	Prelude Therapeutics Inc
2024/05/09	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:PRLD	Prelude Therapeutics Inc
2024/05/07	20:20	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:PRLD	Prelude Therapeutics Inc
2024/05/07	20:12	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PRLD	Prelude Therapeutics Inc
2024/05/07	20:01	GlobeNewswire Inc.	Prelude Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update	NASDAQ:PRLD	Prelude Therapeutics Inc
2024/05/07	05:24	Edgar (US Regulatory)	Form S-3/A - Registration statement under Securities Act of 1933: [Amend]	NASDAQ:PRLD	Prelude Therapeutics Inc
2024/04/10	05:35	GlobeNewswire Inc.	Prelude Highlights Continued Strength of Discovery Engine at 2024 AACR Annual Meeting	NASDAQ:PRLD	Prelude Therapeutics Inc
2024/03/06	06:45	GlobeNewswire Inc.	Prelude Announces Acceptance of Multiple Preclinical Abstracts at the 2024 AACR Annual Meeting	NASDAQ:PRLD	Prelude Therapeutics Inc
2024/03/05	08:07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PRLD	Prelude Therapeutics Inc
2024/03/05	08:07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PRLD	Prelude Therapeutics Inc
2024/03/05	08:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PRLD	Prelude Therapeutics Inc
2024/03/05	08:01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PRLD	Prelude Therapeutics Inc
2024/03/05	07:59	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PRLD	Prelude Therapeutics Inc
2024/03/01	06:05	GlobeNewswire Inc.	Prelude Therapeutics to Participate in Barclays Global Healthcare Conference	NASDAQ:PRLD	Prelude Therapeutics Inc
2024/02/16	07:22	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:PRLD	Prelude Therapeutics Inc
2024/02/16	06:22	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PRLD	Prelude Therapeutics Inc
2024/02/16	06:05	GlobeNewswire Inc.	Prelude Therapeutics Reports Full Year 2023 Financial Results and Outlines Key Objectives for 2024	NASDAQ:PRLD	Prelude Therapeutics Inc
2024/02/13	06:26	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:PRLD	Prelude Therapeutics Inc
2024/01/09	07:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PRLD	Prelude Therapeutics Inc
2023/12/11	23:34	GlobeNewswire Inc.	Prelude Therapeutics Announces $25 Million Private Placement	NASDAQ:PRLD	Prelude Therapeutics Inc
2023/12/11	23:17	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PRLD	Prelude Therapeutics Inc
2023/11/02	05:37	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:PRLD	Prelude Therapeutics Inc
2023/11/02	05:23	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PRLD	Prelude Therapeutics Inc
2023/11/02	05:10	GlobeNewswire Inc.	Prelude Announces Strategic Pipeline Progress and Updates, including its Partnership with AbCellera, and Reports Third Quarter Financial Results	NASDAQ:PRLD	Prelude Therapeutics Inc
2023/11/02	05:05	Business Wire	Prelude Therapeutics and AbCellera Enter Partnership to Develop First-in-Class Precision Antibody Drug Conjugates in Oncology	NASDAQ:PRLD	Prelude Therapeutics Inc
2023/11/02	05:05	GlobeNewswire Inc.	Prelude Therapeutics and AbCellera Enter Partnership to Develop First-in-Class Precision Antibody Drug Conjugates in Oncology	NASDAQ:PRLD	Prelude Therapeutics Inc
2023/10/15	01:30	GlobeNewswire Inc.	Prelude Announces Multiple Clinical and Preclinical Poster Presentations at AACR-NCI-EORTC International Conference	NASDAQ:PRLD	Prelude Therapeutics Inc
2023/10/06	22:07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PRLD	Prelude Therapeutics Inc
2023/08/29	21:30	GlobeNewswire Inc.	Prelude Therapeutics to Participate in Three Healthcare Investor Conferences in September	NASDAQ:PRLD	Prelude Therapeutics Inc
2023/08/03	21:14	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:PRLD	Prelude Therapeutics Inc

검색 관련기사 보기:NASDAQ:PRLD

1 2 3 4 5 6 7 다음 >>

Deutsche Telekom (QX)

Bank of America

BNP Paribas (QX)

Health Care Select Sector

US Dollar vs Yen

US Dollar vs Euro

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관